These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21492999)

  • 1. Ascorbate and endocytosed Motexafin gadolinium induce lysosomal rupture.
    Berndt C; Kurz T; Bannenberg S; Jacob R; Holmgren A; Brunk UT
    Cancer Lett; 2011 Aug; 307(2):119-23. PubMed ID: 21492999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay.
    Donnelly ET; Liu Y; Paul TK; Rockwell S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1176-86. PubMed ID: 15990023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motexafin gadolinium: a novel redox active drug for cancer therapy.
    Magda D; Miller RA
    Semin Cancer Biol; 2006 Dec; 16(6):466-76. PubMed ID: 17112739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis.
    Chen J; Ramos J; Sirisawad M; Miller R; Naumovski L
    Apoptosis; 2005 Oct; 10(5):1131-42. PubMed ID: 16151646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species.
    Magda D; Lepp C; Gerasimchuk N; Lee I; Sessler JL; Lin A; Biaglow JE; Miller RA
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1025-36. PubMed ID: 11704327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.
    Evens AM; Lecane P; Magda D; Prachand S; Singhal S; Nelson J; Miller RA; Gartenhaus RB; Gordon LI
    Blood; 2005 Feb; 105(3):1265-73. PubMed ID: 15388578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
    Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
    Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
    Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motexafin gadolinium reacts with ascorbate to produce reactive oxygen species.
    Magda D; Gerasimchuk N; Lecane P; Miller RA; Biaglow JE; Sessler JL
    Chem Commun (Camb); 2002 Nov; (22):2730-1. PubMed ID: 12510321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines.
    Magda D; Lecane P; Miller RA; Lepp C; Miles D; Mesfin M; Biaglow JE; Ho VV; Chawannakul D; Nagpal S; Karaman MW; Hacia JG
    Cancer Res; 2005 May; 65(9):3837-45. PubMed ID: 15867382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines.
    Lecane PS; Karaman MW; Sirisawad M; Naumovski L; Miller RA; Hacia JG; Magda D
    Cancer Res; 2005 Dec; 65(24):11676-88. PubMed ID: 16357179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular localization of the radiation enhancer motexafin gadolinium using interferometric Fourier fluorescence microscopy.
    Woodburn KW
    J Pharmacol Exp Ther; 2001 Jun; 297(3):888-94. PubMed ID: 11356908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines.
    Skommer J; Wlodkowic D; Pelkonen J
    Exp Hematol; 2006 Apr; 34(4):463-74. PubMed ID: 16569593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.
    Kanick SC; Eiseman JL; Joseph E; Guo J; Parker RS
    J Photochem Photobiol B; 2007 Sep; 88(2-3):90-104. PubMed ID: 17604637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies.
    Evens AM; Balasubramanian L; Gordon LI
    Curr Treat Options Oncol; 2005 Jul; 6(4):289-96. PubMed ID: 15967082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents.
    Wei WH; Fountain M; Magda D; Wang Z; Lecane P; Mesfin M; Miles D; Sessler JL
    Org Biomol Chem; 2005 Sep; 3(18):3290-6. PubMed ID: 16132091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined arginine and ascorbic acid treatment induces apoptosis in the hepatoma cell line HA22T/VGH and changes in redox status involving the pentose phosphate pathway and reactive oxygen and nitrogen species.
    Hsieh BS; Huang LW; Su SJ; Cheng HL; Hu YC; Hung TC; Chang KL
    J Nutr Biochem; 2011 Mar; 22(3):234-41. PubMed ID: 20558052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motexafin gadolinium-induced cell death correlates with heme oxygenase-1 expression and inhibition of P450 reductase-dependent activities.
    Evans JP; Xu F; Sirisawad M; Miller R; Naumovski L; de Montellano PR
    Mol Pharmacol; 2007 Jan; 71(1):193-200. PubMed ID: 17018578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.